MedTrace Logo

The Prevalence of Sub Optimal Anti Coagulation

NCT03485300 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-07-03

No results posted yet for this study

Summary

A study on warfarin administration to show whether noncompliance of the patient will affect our target (INR) during therapy or not beside its drug and dietary interactions.

The study will show the prevalence of sub optimal anti coagulation among patients with prosthetic cardiac valves that will undergo warfarin therapy.

Conditions

  • Poor Drug Response

Interventions

DIAGNOSTIC_TEST

Liver and kidney function tests for patients with chronic liver or kidney diseases

Tests will be done to patients with history suggestive of chronic liver or renal diseases or for patients clinically suspected

BEHAVIORAL

Non compliance of the patient

I will order all my patients to take the drug at 10 am and assure the daily in taking of the dose and they will be followed up

DRUG

Drug or food interactions

The patient will be in contact with the researcher for any drug added with warfarin in case of other co morbidity conditions and follow up his/her CBC and INR for measuring its effect on warfarin finding out the effect of food on warfarin therapeutic outcome

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2019-05-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485300 on ClinicalTrials.gov